A 23-Gene Classifier urine test for prostate cancer prognosis

Affiliations

• ¹ Shenzhen People's Hospital (The Second Clinical Medical College, Jinan University; The First Affiliated Hospital, Southern University of Science and Technology), Shenzhen Urology Minimally Invasive Engineering Centre, Shenzhen, China.
• ² Shenzhen Public Service Platform on Tumor Precision Medicine and Molecular Diagnosis, Clinical Medical Research Centre, Shenzhen, China.
• ³ Olympia Diagnostics, Inc., Sunnyvale, California.
• ⁴ Department of Bio-Diagnosis, Institute of Basic Medical Sciences, Beijing, China.
• ⁵ Department of Clinical Pathology and Cytology, Skåne University Hospital, Malmö, Sweden.
• ⁶ Clinical Laboratories, San Francisco General Hospital, San Francisco, California.
• ⁷ Department of Urology, Foshan First People's Hospital, Foshan, China.
• ⁸ Department of Urology, Nanfang Hospital, Southern Medical University, Guangzhou, China.
• ⁹ Kinetic Reality, Santa Clara, California.
• ¹⁰ Department of Translational Medicine, Lund University, Clinical Research Centre, Malmö, Sweden.
• ¹¹ Department of Experimental Pathology, Medical University Vienna & Unit of Laboratory Animal Pathology, University of Veterinary Medicine, Vienna, Austria.
• ¹² Department of Urology, The First Affiliated Hospital of Sun Yat-Sen University, Guangzhou, China.
• ¹³ Department of Molecular Biology, Umeå University, Umeå, Sweden.
• ¹⁴ Department of Biomedical Sciences, Malmö University, Malmö, Sweden.
• ¹⁵ Division of Experimental Cancer Research, Department of Translational Medicine, Lund University, Malmö, Sweden.